stockportfolio.pro
Stocks / IPX vs UAMY
IPX vs UAMY
IperionX Limited and United States Antimony Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Basic Materials.
| IperionX Limited (IPX) | United States Antimony Corporation (UAMY) | |
|---|---|---|
| Market cap | $1.2B | $1.0B |
| Revenue (latest FY) | $0 | $39.26M |
| Net income (latest FY) | $-21.84M | $-4.34M |
| Revenue growth (5y CAGR) | — | 49.6% |
| Net margin | — | -11.1% |
| Return on equity | -42.5% | -3.1% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 2 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open IPX — free Open UAMY — freeFrequently asked questions
Which is bigger, IPX or UAMY?
IperionX Limited is larger by market capitalization — $1.2B versus $1.0B.
Which grows faster, IPX or UAMY?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.